How AOD-9604 Works (in Brief) AOD-9604 was engineered from the C-terminal segment of human growth hormone (amino acids 177191) the portion thought to influence fat metabolism. In preclinical models, this fragment supported fat oxidation and lipid mobilization without the broader hormonal effects of full-length hGH. Because it does not activate the traditional hGH receptor, its fat-metabolism effects are considered indirect and receptor-independent. Discovery & Research Milestones Originally developed in the 1990s as a potential anti-obesity drug
Safe & Trusted Source Unlike unregulated online options, our peptides come from reputable medical sources
Covarrubias AJ, Perrone R, Grozio A, Verdin E
Cagrilintide is best understood as an investigational amylin analog, while tirzepatide has approved product labels for specific uses
Combining BPC-157 with a proton pump inhibitor in preclinical models could theoretically address both acid suppression and mucosal repair simultaneously
Nougier C, Benoit R, Simon M